Symphogen
Tania Køllgaard has a diverse work experience in the field of scientific research and project management. Tania started their career as a Scientific Assistant at Kræftens Bekæmpelse (Danish Cancer Society) in 2005 and then moved on to work as a PhD at CCIT - Center for Cancer Immune Therapy from 2007 to 2012. Following that, they worked as a Scientific Assistant at CCIT and later joined Rigshospitalet as a Post doc from 2013 to 2017. Tania then transitioned to Evaxion Biotech, where they held the role of Project Manager - Immuno-Oncology from 2017 to 2019. Currently, they are working as a Senior Scientist at Symphogen since June 2019.
Tania Køllgaard obtained their M.Sc. degree in Molecular Biology from Aarhus University between the years 1999 and 2005.
Symphogen
3 followers
Symphogen is a clinical-stage antibody oncology focused company with a differentiated product pipeline and significant commercial opportunities. Inspired by nature, led by science and driven by people, we passionately strive to make that discovery that may have great effect on the lives of patients, their families, and their caregivers. Based on our monoclonal antibody (mAb) research platform, we create differentiated mAb and mAb mixture products candidates. Our pre-clinical and clinical pipeline is well suited for a precision-medicine approach by addressing well-defined, biomarker-selected patient populations. We are headquartered in Denmark with operations in the US.